Healthcare Dec 29, 2021 09:18 PM (GMT+8) · EqualOcean
On December 29, the State Food and Drug Administration (nmpa) of China announced that the listing application of aidinafil citrate tablets of yuekang pharmaceutical has been approved. According to the public data, aidinafil citrate is a type 5 phosphodiesterase (PDE5) inhibitor, and the approved indication of this drug is male erectile dysfunction.